My main clinical and research interests are drug delivery with nano-particle through blood brain barrier (BBB) and drug discovery with focus on promising new targeted therapeutic agents i.e. M-Tor inhibitor, EGFR-TKI, VEGFR, Monoclonal antibody, Gene therapy and Immunotherapy with Vaccine and Stem cell for different specific cancer cell targets including correlation with proteinomic, genomic profile in order to avoid major side effects and maintain high quality of life in this group of patients with the ultimate goal of offering personalized Neuro-Oncology medicine for every patient with brain cancer. I have more than 20 years of experience in this field for translational clinical research
View More
